What is the Difference Between Congenital Adrenal Hyperplasia and Hypoplasia?

Congenital Adrenal Hyperplasia (CAH) and Congenital Adrenal Hypoplasia (CAH) are both genetic disorders that affect the adrenal glands, which produce important hormones. However, they have distinct differences in their causes, symptoms, and treatments.

Congenital Adrenal Hyperplasia (CAH):

CAH is a group of genetic disorders caused by a mutation in the 21-hydroxylase enzyme, which is responsible for making hormones in the adrenal glands.
The two main types of CAH are classic and non-classic, with the classic form being diagnosed at birth and the non-classic form typically diagnosed during adolescence.
Symptoms of CAH may include excess androgen production, atypical genitalia in female infants, and an adrenal crisis, which can be life-threatening.
Treatment for CAH depends on the type and severity, with the goal of reducing excessive hormones and replacing deficient ones.

Congenital Adrenal Hypoplasia (CAH):

CAH, also known as Adrenal Hypoplasia Congenita (AHC), is a condition in which there is underdevelopment or hypotrophy of the adrenal cortex due to several clinical conditions.
Causes of adrenal hypoplasia include PCSK1 enzyme defect, isolated ACTH deficiency, diseases of pituitary development, central nervous system developmental anomalies, and chronic exogenous glucocorticoid treatment.
Symptoms of CAH may include failure to thrive, salt wasting, hyperpigmentation, and elevated 17-hydroxyprogesterone and 11-deoxycortisol levels.
Prognosis for untreated CAH is poor, with death being a common outcome if the disorder is unrecognized or untreated.

It is crucial to distinguish between these two conditions, as their treatments and prognoses differ.

On this page

What is the Difference Between Congenital Adrenal Hyperplasia and Hypoplasia?

Comparative Table: Congenital Adrenal Hyperplasia vs Hypoplasia

Congenital Adrenal Hyperplasia (CAH) and Congenital Adrenal Hypoplasia (AHC) are both genetic disorders affecting the adrenal glands, but they have distinct differences in their presentation, causes, and treatments. Here is a table comparing the two conditions:

Feature	Congenital Adrenal Hyperplasia (CAH)	Congenital Adrenal Hypoplasia (AHC)
Description	CAH is a group of genetically determined disorders involving enzymatic defects, with the most common being 21-hydroxylase deficiency.	AHC is a rare developmental disorder of the human adrenal cortex, caused by deletion or mutation of the DAX-1 gene.
Presentation	CAH typically presents with life-threatening effects on metabolism and electrolytes, along with the accumulation of androgens.	AHC generally presents with failure to thrive, salt wasting, hypoglycemic convulsions, and hyperpigmentation in the first months of life.
Hormone Levels	Elevated levels of 17-hydroxyprogesterone and markedly elevated 11-deoxycortisol levels are seen in CAH.	Plasma concentrations of mineralocorticoids and glucocorticoids are decreased in AHC, with no response to ACTH stimulation.
Treatment	CAH treatment aims to reduce androgen levels, replace glucocorticoids, and manage electrolyte and mineral imbalances.	AHC treatment focuses on replacing missing hormones, such as glucocorticoids and mineralocorticoids.
Prognosis	With proper treatment, CAH can be managed, and individuals can lead relatively healthy lives.	If untreated, AHC can have a poor prognosis, leading to severe complications or even death.
Frequency	CAH is more common than AHC, with an estimated frequency of 1 in 12,500 births.	AHC is much rarer, with an estimated frequency of 1 case per 12,500 births in Japan.

It is crucial to differentiate between CAH and AHC, as their treatments and prognoses differ significantly.

Guilherme Mazui

Guilherme Mazui is graduated in journalism from the Federal University of Minas Gerais (UFMG) and a master's degree in Communication from the University of São Paulo (USP). In addition, he has experience in advertising writing and has worked as a content editor in several companies.